HomeBUSINESS
BUSINESS

Santen’s FY2015 Profits Zoom on Sale of RA Business
(May.13.2016)

Santen Pharmaceutical delivered a strong scorecard in FY2015 ended March, enjoying sharp gains in profits following the divestment of its rheumatoid arthritis business to Ayumi Pharmaceutical last year ...
(LOG IN FOR FULL STORY)

News Calendar